Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
Aim. Evaluation of sarcopenia’s effect on hepatotoxicity in patients with locally advanced and metastatic pancreatic cancer (PC).Materials and methods. A retro-prospective study included 66 patients (30 men and 36 women) with locally advanced and metastatic PC receiving chemotherapy treatment in the...
Saved in:
Main Authors: | A. A. Klunichenko, A. P. Seryakov, A. A. Seryakova, S. M. Demidov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2020-07-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/314 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical risk factors for sarcopenia in acute and chronic pancreatitis
by: Mitchell L. Ramsey, et al.
Published: (2025-02-01) -
Clinical impact of the prognostic nutritional index and skeletal muscle index for the incompletion of adjuvant chemotherapy for pancreatic cancer
by: Hiromitsu Maehira, et al.
Published: (2025-02-01) -
Artificial intelligence for body composition assessment focusing on sarcopenia
by: Sachiyo Onishi, et al.
Published: (2025-01-01) -
Sarcopenia as a Predictor of Mortality in a Cohort of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
by: Giacomo Mulinacci, et al.
Published: (2024-12-01) -
Low skeletal muscle mass as a proxy marker of sarcopenia is a risk factor for major complications in older patients undergoing curative colon resections for colon cancer
by: İsmail Tırnova, et al.
Published: (2025-01-01)